# Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis

> **NCT03654144** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Adenomyosis

## Interventions

- **DRUG:** Dienogest
- **DRUG:** Combined Oral Contraceptive

## Key facts

- **NCT ID:** NCT03654144
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11
- **Primary completion:** 2019-12
- **Final completion:** 2020-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03654144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03654144, "Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03654144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*